UNPRI

Golding Capital Partners GmbH: Final closing: Golding closes two infrastructure funds well above target – at a total of €1.5 billion

Retrieved on: 
Monday, September 5, 2022
Banking, Asset Management, Professional Services, Finance, Recycling, APriori Capital Partners, United Nations Principles of Medical Ethics, Insurance, Socially responsible investing, Investment, Foundation, Task force, Geography, UNPRI, Infrastructure, Security (finance), Renewable energy, Golding

Golding Capital Partners, one of Europes leading independent asset managers for alternative investments, has held successful final closings for its two current infrastructure funds, with total commitments of some 1.5 billion.

Key Points: 
  • Golding Capital Partners, one of Europes leading independent asset managers for alternative investments, has held successful final closings for its two current infrastructure funds, with total commitments of some 1.5 billion.
  • The flagship fund of funds Golding Infrastructure 2020 closed at 943 million, significantly above its target of 700 million.
  • Golding Infrastructure Co-Investment 2020 also closed well above its original target at 578 million, thanks to strong investor demand.
  • Eight subscriptions of primary funds, co-investments and secondary funds have already been made for the fund of funds.

DGAP-News: Golding Capital Partners GmbH: Final closing: Golding closes two infrastructure funds well above target – at a total of €1.5 billion

Retrieved on: 
Monday, September 5, 2022
Recycling, APriori Capital Partners, United Nations Principles of Medical Ethics, Insurance, Socially responsible investing, Investment, Foundation, Task force, Geography, UNPRI, Infrastructure, Security (finance), Renewable energy, Golding

Munich, 5th September 2022 Golding Capital Partners, one of Europes leading independent asset managers for alternative investments, has held successful final closings for its two current infrastructure funds, with total commitments of some 1.5 billion.

Key Points: 
  • Munich, 5th September 2022 Golding Capital Partners, one of Europes leading independent asset managers for alternative investments, has held successful final closings for its two current infrastructure funds, with total commitments of some 1.5 billion.
  • The flagship fund of funds Golding Infrastructure 2020 closed at 943 million, significantly above its target of 700 million.
  • Golding Infrastructure Co-Investment 2020 also closed well above its original target at 578 million, thanks to strong investor demand.
  • Eight subscriptions of primary funds, co-investments and secondary funds have already been made for the fund of funds.

Legend Capital: The Logic of Technology Investment Has Changed

Retrieved on: 
Friday, September 2, 2022
Technology, Venture capital, China concepts stock, WuXi Biologics, IFlytek, VC, TMT, Home, Health, STAR, Science, ChiNext, Map, Mission statement, Time, Japan Exchange Group, KOSDAQ, USD, Korea Exchange, History, London Stock Exchange Group, ESG, Industry, Specialization, CRO, New York Stock Exchange, Lithium, R, Judgement, Hong Kong Stock Exchange, Innovation, Investment, Pony.ai, Wuxi, Shenzhen Stock Exchange, Shanghai Stock Exchange, Taiwan Stock Exchange, Logic, Star Market, IPO, Architecture, Differentiation, Interview, Refinement, Radar, Environment, UNPRI, Initial public offering, CATL, Security (finance), Fine chemical, Renewable energy, Bank, Video game, Cryptocurrency, Nasdaq, RMB

In a recent interview, Richard Li, President of Legend Capital, revealed the history of Legend Capital in technology investment, and proposed that the logic of technology investment has undergone important changes.

Key Points: 
  • In a recent interview, Richard Li, President of Legend Capital, revealed the history of Legend Capital in technology investment, and proposed that the logic of technology investment has undergone important changes.
  • Richard Li, President of Legend Capital, said in the interview: "What matters is not about the quantity of IPOs, but more about the repeated verification of the investment expertise of Legend Capital team, who has long been rooted in technology investment.
  • Looking back at Legend Capital's development history, we can see a microcosm of the changes in China's technology investment.
  • So far, among Legend Capital's invested companies, there are over 100 unicorn companies with a valuation of over USD1 billion, creating a huge and systematic technology investment footprint.

Noble Announces Leadership Promotions and New Appointments

Retrieved on: 
Thursday, August 25, 2022
Pension, View, Warwick Investment Group, Cornell School District (Allegheny County, Pennsylvania), Associate, Real estate, Student, Multimedia, Diversity, Leadership, Foundation, Firefighter, Noble, Law enforcement, Acquisition, Growth, Industry, UNPRI, Travel, Management, Risk management

ATLANTA, Aug. 25, 2022 /PRNewswire/ -- Noble Investment Group ("Noble") today announced promotions and new leadership appointments across its asset management, capital markets, communications, investment, and investor relations teams.

Key Points: 
  • ATLANTA, Aug. 25, 2022 /PRNewswire/ -- Noble Investment Group ("Noble") today announced promotions and new leadership appointments across its asset management, capital markets, communications, investment, and investor relations teams.
  • To support the firm's continued growth, several team members have further enhanced their leadership within the organization, and Noble has also added talent and leadership to new roles within the organization:
    Dan Konzelmann has been promoted to Senior Director.
  • "I remain proud of these Noble leaders, who represent the outstanding depth and breadth of diverse talent we continue to develop in our organization," said Noble CEO Mit Shah.
  • "These appointments demonstrate our commitment to recruiting top talentas we continue to expand the depth and breadth of our hospitality investment strategies," said Noble CEO Mit Shah.

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

Retrieved on: 
Friday, August 19, 2022
Map, Precision medicine, AI, Technology, CRO, VC, Research, Life, ESG, Mass spectrometry, Proteomics, CNY, RMB, Health, Biotechnology, UNPRI, Metabolomics, Big data, USD, Fine chemical

HONG KONG, Aug 19, 2022 - (ACN Newswire) - Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital.

Key Points: 
  • HONG KONG, Aug 19, 2022 - (ACN Newswire) - Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital.
  • Ms. CHEN Wei, the founder of APTBIO, said: "I would like to take this opportunity to extend my sincere gratitude to our investors.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

DGAP-News: Golding Capital Partners GmbH: ”Golding Buyout 2021” reports first closing at €155 million

Retrieved on: 
Thursday, August 18, 2022
Â, APriori Capital Partners, Technology, Growth, Investment, Golding, Task force, Foundation, Health, UNPRI, Insurance, United Nations Principles of Medical Ethics, Socially responsible investing, B2B, Security (finance), Financial services

Investments via experienced fund managers in fast-growing, small and medium companies in the sectors technology, healthcare and B2B services

Key Points: 
  • Investments via experienced fund managers in fast-growing, small and medium companies in the sectors technology, healthcare and B2B services
    Munich, 18 August 2022 Golding Capital Partners, one of Europes leading independent asset managers for alternative investments, announces the first closing of its fund Golding Buyout 2021 at 155 million.
  • The funds target volume is 400 million, with a final closing planned for the end of 2023.
  • With our strategy we are not only offering investors access to the established buyout markets of North America and Europe.
  • Golding Capital Partners GmbH is one of Europes leading independent asset managers for alternative investments, focusing on the asset classes infrastructure, private credit, private equity, secondaries and impact.

DGAP-News: Golding Capital Partners GmbH: Golding holds first closing with global impact fund

Retrieved on: 
Tuesday, August 16, 2022
APriori Capital Partners, Climate change, IRR, Growth, Investment, Agriculture, Classification, Golding, Entrepreneurship, Task force, Foundation, Article 8 of the European Convention on Human Rights, UNPRI, Insurance, Science and technology in Asia, Solution, Time, United Nations Principles of Medical Ethics, Socially responsible investing, Food, Efficiency, SFDR, Security (finance), Renewable energy, Financial services

Besides impact expertise, sufficient diversification is crucial when selecting a fund manager, says Dr. Andreas Nilsson, Head of Impact Investing at Golding.

Key Points: 
  • Besides impact expertise, sufficient diversification is crucial when selecting a fund manager, says Dr. Andreas Nilsson, Head of Impact Investing at Golding.
  • The strategy of the Golding Impact 2021 is to build a broadly diversified portfolio across sectors, regions and development stages.
  • The Golding Impact 2021 allows investors to make measurable contributions to mitigating climate change and global inequality.
  • Golding Capital Partners GmbH is one of Europes leading independent asset managers for alternative investments, focusing on the asset classes infrastructure, private credit, private equity, secondaries and impact.

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

Retrieved on: 
Monday, August 15, 2022
ChiNext, Industry, R, CRO, Clinical trial, VC, Data management, ESG, WuXi AppTec, WuXi Biologics, D, RMB, Health, Series, UNPRI, Shenzhen Stock Exchange, USD, Fine chemical, Bellen

HONG KONG, Aug 15, 2022 - (ACN Newswire) - On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange.

Key Points: 
  • HONG KONG, Aug 15, 2022 - (ACN Newswire) - On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange.
  • Legend Capital invested in the Series A round of R&G PharmaStudies in the second half of 2017 and has kept on supporting the development of R&G PharmaStudies.
  • Jafar Wang, the Co-Chief Investment Officer of Legend Capital, said, "Congratulations on the successful listing of R&G PharmaStudies!
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully

Retrieved on: 
Tuesday, August 9, 2022
Intellectual property, Investment, VC, ESG, Patient, WuXi Biologics, Infection, RMB, Star Market, Therapy, Health, UNPRI, Medication, USD, Pharmaceutical industry

HONG KONG, Aug 9, 2022 - (ACN Newswire) - On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market.

Key Points: 
  • HONG KONG, Aug 9, 2022 - (ACN Newswire) - On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market.
  • MicuRx Pharmaceuticals issued 130,000,000 shares this time, accounting for 19.84% of the total share capital after the issuance.
  • Legend Capital invested in MicuRx Pharmaceuticals in 2020 and has long supported the company's development.
  • Legend Capital and the MicuRx team have established a deep friendship, and Legend Capital is honored to participate in the MicuRx business led by Dr. Zhengyu YUAN, the founder of MicuRx Pharmaceuticals.

New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B

Retrieved on: 
Monday, August 8, 2022
Synthetic biology, Whitelisting, CATL, Carbon, Industry, Technology, VC, ESG, Recycling, RMB, Health, Automation, Lithium, CAGR, UNPRI, Milky Way, Carbon footprint, USD, Electric battery

Meanwhile, centering on the national carbon peaking and carbon neutrality policies, Ruicycle has achieved the traceability of carbon footprint and the quantification of carbon reduction, continuously making contributions to low-carbon development for the new energy industrial chain.

Key Points: 
  • Meanwhile, centering on the national carbon peaking and carbon neutrality policies, Ruicycle has achieved the traceability of carbon footprint and the quantification of carbon reduction, continuously making contributions to low-carbon development for the new energy industrial chain.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
  • Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.